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Abstract
Background: Germ cell tumors are tumors composed of tissues derived from more than one of the three germinal
layers. They are more common in the testes and ovaries, but can present in many different regions in the midline,
including the sacral region, retroperitoneum, mediastinum, and brain. Testicular germ cell tumors generally
metastasize to the retroperitoneum, lungs, and brain; metastases to soft tissue are very rare.
Case presentation: Here we describe a case of a single soft-tissue mass in the thigh of a 27-year-old man, with
histology showing areas of mature teratoma tissues derived from the ectodermal and mesodermal lineages, and
areas of immature teratoma tissue composed of small undifferentiated cells, with primitive neuroectodermal
differentiation foci forming neuroepithelial elements – thus classified as immature teratoma. The patient had no
other clinical or radiological evidence of involvement, besides the lymph nodes.
Conclusion: The case presented suggests a rare and unexpected primary immature teratoma of the thigh.
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Background
Teratoma is a subtype of germ cell tumors (GCT) de-
rived from more than one of the three germinal layers.
Teratomas can be classified as mature tumors (cystic or
solid), which contain well-differentiated tissues, or as
immature tumors, which contain poorly differentiated
tissues consisting primarily of embryonic-appearing neu-
roglial or neuroepithelial components [1, 2]. The most
commonly involved sites of teratomas are the sacrococ-
cygeal region (57 %) and the gonads (29 %); they occur
much more frequently in the ovaries, but can also arise
in the testes. In adults, the gonads are by far the most
common site of teratomas. Other possible locations are
the mediastinum (7 %), retroperitoneum (4 %), cervical
region (3 %), and intracranial (3 %) [3]. Uncommon lo-
cations are the stomach, heart, pleura, pharynx, thyroid,
base of the skull, maxilla, liver, prostate, vagina, and sub-
cutaneous tissues [2, 4].
GCTs represent 95 % of testicular tumors developing
after puberty, although pure teratomas of the testis are
rare (3–5 %). In men, teratomas of the testis developing
during and after puberty are always considered to be
malignant because of the potential for metastasis, mainly
to the retroperitoneal lymph nodes [3]. According to
Ghazarian et al. [5], almost 90,000 cases of testicular
GCTs in men were registered in the US between 1998
and 2011.
The prognosis of teratomas depends on many factors.
Mature teratomas are generally benign. Immature tera-
tomas in young children also tend to behave as benign
tumors. In patients older than 15 years, immature terato-
mas can manifest as highly devastating malignancies [1].
Metastases of testicular teratomas to the subcutaneous
tissues are very rare. Only two cases of primary testicular
teratomas that metastasized to soft tissue (the left thigh
and gluteal and iliac muscles, respectively) have been re-
ported in the literature [6, 7]. In addition, the literature
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contains only four descriptions of GCTs arising primar-
ily from structures away from the midline [8–11]. Here
we present the first reported case of an immature tera-
toma manifesting as a subcutaneous mass in the thigh,
with no evidence of other sites of involvement, except
the lymph nodes.
Case presentation
A 27-year-old man presented to his city’s health service
(in the Midwest of the state of Santa Catarina, Brazil) in
February 2010 complaining of a nodule in the middle
third of the lateral aspect of his right thigh. The mass was
removed surgically and sent for pathological examination,
which revealed a 105 g piece, measuring 10.5 × 8.5 ×
4 cm, covered by white skin. In the central portion of der-
mis/hypodermis, there was a brownish, lobulated, soft,
and friable nodule, measuring 6.5 × 5 × 3.5 cm, partially
encapsulated. The deep margin was covered by whitish
and smooth muscle fascia (Fig. 1a and 1b). Histological
sections stained with hematoxylin-eosin showed mature
and immature teratoma, with presence of areas of mature
teratoma with tissues derived from ectodermal and meso-
dermal lineages (Fig. 1c and 1d), and areas of immature
teratoma composed of small undifferentiated cells (Fig. 1e)
with foci of primitive neuroectodermic differentiation
forming neuroepithelial elements (Fig. 1f). The prevalence
Fig. 1 Gross specimen of the tumor, after the first surgery, with muscle fascia (a) and epidermis side (b). c Histological section showing immature
teratoma (left), represented by blocks of undifferentiated neoplasm (asterisk). On the right, areas of mature teratoma composed of well differentiated
tissue with corneal cysts (arrows) and islands of adipose tissue (arrowhead). (Hematoxylin & Eosin, 40× magnification); d Island of cartilaginous tissue of
mesodermal lineage (mature teratoma), surrounded by undifferentiated cells (immature teretoma), (Hematoxylin & Eosin, 100× magnification);
e areas of immature teratoma composed of blocks of undifferentiated neoplasm. In the lower picture, small undifferentiated cells with mitotic
figures (arrows), (Hematoxylin & Eosin, 100× magnification, and lower frame 400× magnification); f Immature teratoma composed of small
undifferentiated cells with foci of primitive neuroectodermic differentiation forming neuroepithelial elements (arrows), (Hematoxylin & Eosin,
400× magnification)
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of immature teratoma was estimated to be 70 %. Margins
were compromised, and a sample was sent for immuno-
chemical analysis.
While waiting for the immunochemical results, the pa-
tient was referred to the Oncology Service of Hospital
Universitário Santa Terezinha (HUST). He presented at
this service in May, 2010 with a hard nodule (diameter
~5 cm) in his right thigh, in the same location from
which the previous mass was removed. Computed tom-
ography (CT) of the thigh revealed a mass in the lateral
aspect of the thigh (Fig. 2a). Findings of chest CT and
chest radiography, conducted as part of the workup to
assess possible sarcoma, were negative. The testes were
also normal, as determined by CT (Fig. 2b).
Immunochemical results, available in June 2010,
demonstrated positivity for cytokeratin (AE1 and AE3
clones), CD99 and MIC2 (Ewing’s sarcoma and 12E7
markers), PS100 (anti-human S-100), Wilm’s tumor 1
(WT1, 6 F-H2 clone), desmin (D33 clone), and vimentin
(V9 clone), consistent with an immature teratoma. The
patient underwent a second surgery to remove the mass.
Analysis of the second resection specimen revealed a
yellowish, irregular node, partially encapsulated and greasy
to the touch, weighing 24 g and measuring 4.8 × 3.8 ×
1.8 cm. Surgical margins were free and there was no
perineural or angiolymphatic invasion. The patient was
scheduled for follow up.
In November 2010, the patient presented to the On-
cology Service of HUST with a right inguinal node.
Ultrasound of the testis and CT of the brain were normal.
CT of the pelvis and abdomen revealed enlarged lymph
nodes, measuring up to 2.7 cm, in the right inguinal region
and retroperitoneum. No other abnormalities were seen.
The patient’s alpha-fetoprotein (AFP) level was 375.7 ng/ml
(normal value < 15 ng/ml, slightly varying among laborator-
ies) and his β–human chorionic gonadotropin (β-hCG)
level was 0.1 mIU/ml (normal value < 2,67 mIU/ml, slightly
varying among laboratories). At this point, the patient was
started on bleomycin, etoposide, and cisplatin, and was
followed regularly. The right inguinal node regressed.
In May 2011, the patient presented to the Oncology Ser-
vice of HUST with right inguinal pain. Physical examin-
ation revealed no right inguinal lymph node or testicular
abnormality. The patient returned in June 2011 with right
inguinal enlargement, up to 2.5 cm. Serum levels of AFP
and β-hCG were 5.6 ng/ml and 0.1 mIU/ml, respectively.
The right inguinal lymph node was biopsied in August
2011 and sent for immunochemical analysis. This analysis
revealed positivity for FLI-1 (Friend leukemia integration 1
transcription factor), (MRQ-1) and synaptophysin (anti-
synaptophysin, SY38 clone) and negativity for thyroid
transcription factor 1 (SPT24 clone), WT-1 (6 F-H2
clone), PS100 (anti-human S-100), CD99 and MIC2 (12E7
clone), cytokeratin (AE1 and AE3 clones), chromogranin
A (DAK-A3 clone), and desmin (D33 clone). Laboratory
findings received in September 2011 showed that the
patient’s AFP level was 35.6 ng/ml and his β-hCG level
was 2.3 mIU/ml. The patient was started on rescue
chemotherapy with paclitaxel, ifosfamide, and cisplatin
in February 2012. Thereafter, concentrations of the
tumor markers AFP and β-hCG were 5.6 ng/ml and 0.6
mIU/ml, respectively.
In March 2012, the patient presented with pain in his
right thigh. His AFP level was 61.4 ng/ml and his β-hCG
level was 4.8 mIU/ml. CT of the thigh revealed recurrence
of the mass. Right inguinal node enlargement was also
noticed.
In May 2012, the patient returned to the Oncology
Service of HUST with a palpable node in his left breast,
in addition to the inguinal and thigh nodules. In June
2012, his AFP level was 1,101.8 ng/ml and his β-hCG
level was 1.5 mIU/ml. The patient was started on pallia-
tive chemotherapy with the VIP (vinblastine, ifosfamide,
and cisplatin) protocol. By the end of June 2012, after
the first cycle of VIP, the patient developed neutropenic
fever, septic shock, acute kidney injury and finally died
in consequence of these complications.
Discussion
The case presented in this article is very rare, and it is
the first reported case of an immature teratoma in the
Fig. 2 a Axial CT image of the inferior extremities shows a muscle-
density mass in the lateral aspect of the right thigh, measuring
38 × 20 mm (arrow). b Axial CT image of the perineum at the
testes level shows the lack of disease in these structures
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subcutaneous tissue of the thigh with no evidence of a
primary tumor site. As this case is unusual, many ques-
tions arise. The first question is whether the tumor aris-
ing in the subcutaneous tissue was a teratoma, rather
than a sarcoma. Our answer is that the immunochemical
findings were clear and concise. The positivity for all im-
munochemical markers and the elevation of characteris-
tic serological tumor markers allow us to have no doubt
about the histologic type of the tumor. Common immu-
nochemical markers for sarcoma are vimentin, keratin,
desmin, leucocyte common antigen, and S100 [12], but
not CD99 and MIC2, which characterize primitive
neuroectodermal components, a hallmark of immature
teratomas [13, 14]. The second question is how an im-
mature teratoma can first present in the subcutaneous
tissue of the thigh, with no evidence of a primary
tumor. We propose two theories to explain this fact.
First, an undetected primary tumor may have been unable
to grow in its original site, leading to clinical evidence of
only metastatic disease. Second, the thigh may have been
the primary site of the tumor.
We would like to emphasize the absence of findings in
our patient’s brain, chest, pelvic, and abdominal CT, with
positivity only for the retroperitoneal and inguinal lymph
nodes. In addition, ultrasound of the testes was normal,
and physical examination of the four extremities and
neck were also normal.
We found in the literature two reported cases of im-
mature teratomas with soft-tissue metastases, interest-
ingly, to the thigh and the gluteal region [6, 7]. Both
cases involved clear primary gonadal tumors, in contrast
to our case. We also found descriptions of four cases of
GCTs arising outside of the midline, without evidence of
a primary tumor; the authors considered these GCTs to
be primary tumors [8–11]. One of these reports de-
scribes a malignant mixed GCT in the soft tissue of the
right arm of a 37-year-old man, with no other sites of
involvement; in this case, immunochesmistry was not
performed, and serum markers for GCT were within
normal limits [8]. Another report describes the case of a
malignant teratoma in the left proximal humerus of a
14-year-old girl. Also in this case, no other sites of dis-
ease were found [9]. In this case, immunochemical find-
ings were consistent with a GCT. An extragonadal
malignant teratoma of the foot [10] and an intraosseous
teratoma of the ilium [11], both without evidence of
other sites of involvement that could suggest a primary
tumor, have also been described.
Teratomas originate from germ cells, which first ap-
pear in the endoderm of the yolk sac and then migrate
to the genital ridges, through the wall of the midgut,
during the fifth week of gestation. The abnormal migra-
tion of germ cells in the intrauterine period can lead to
GCTs in extragonadal locations. Our patient had normal,
topic testes. Although ectopic testes can be found in the
medial thigh [15], we found no evidence in the literature
that they can be located in the lateral aspect. We thus
assume that the tumor in this case was not gonadal in
origin.
The lower limb begins to grow in the fourth week of
embryonic development, arising from the sacral region
opposite the fifth lumbar and first sacral somites. At the
6–9-mm stage, in approximately the fourth gestational
week, the limb bud lengthens and the base extends to-
ward the sacral myotomes [16–18]. The sacrococcygeal
region, from which the lower limb arises, is one of the
most common locations for immature teratoma develop-
ment, especially in infants. We speculate that germ cells in
the sacrococcygeal region can become trapped and follow
the lower limb during its development in this case.
During the course of the disease, our patient developed
inguinal and retroperitoneal lymph node enlargement.
This drainage route is consistent with dissemination from
the thigh, first to the superficial and deep inguinal nodes
and then to the external iliac and aortic nodes. Lymphatic
drainage of the testes occurs first to the interaortocaval
and left para-aortic lymph nodes, just below the renal ves-
sels (as classically seen in metastatic GCT of the testes).
Thus, we hypothesize that the lymph node metastases in
this case likely originated from the thigh [19–21].
If we assume that the mass in the thigh was secondary
to a primary occult tumor (e.g., testicular or retroperi-
toneal), it likely developed through hematogenous dis-
semination (as retrograde lymphatic dissemination is
very unlikely), though it is uncommon for a GCT. Bilici
et al. [7] reported a case of a stage IA immature teratoma
of the testis that was treated surgically. The tumor re-
lapsed years after treatment, with, among others, a mass
in the thigh that was proven histologically to be an imma-
ture teratoma. In that case, however, the patient also had
multiple lung, liver, mediastinal, and brain metastases,
rather than the single metastasis that characterizes our
case [7].
Soft-tissue metastases of a solid tumor are generally
uncommon; it usually occurs in the setting of advanced,
relapsed malignancy [7, 21]. On the other hand, Damron
and Heiner stated that metastatic soft-tissue masses
present most commonly before or concomitant with the
primary malignant sites [22]. Contrary to that statement,
in this case, we have a single soft tissue mass, which hardly
could represent a metastatic mass, since no evidence of
other site of involvement was found.
Conclusions
The case presented here is challenging and unique. None
of the hypothesis that we have developed to explain it –
either a soft-tissue metastasis as the initial presentation of
an immature teratoma arising in an unknown primary site
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or a primary immature teratoma arising in the thigh from
germ cells sequestered abnormally in a location never pre-
viously described – matches evidence in the literature.
The first hypothesis – a single metastasis to soft tissue
with no evidence of disease in any organ except the lymph
nodes – could be considered more probable, given the
premise that GCTs do not arise outside of the midline.
We found only two reported cases in which teratomas
spread to soft tissue, but definite primary sites were identi-
fied in both cases. In the present case, the testes may have
been the primary site of the tumor; after a single metasta-
sis to the subcutaneous tissue of the thigh, the original le-
sion may have undergone spontaneous necrosis and was
no longer clinically evident. The second hypothesis, that
the soft-tissue mass was primary, is supported by four
other described cases of GCTs outside the midline with
no evidence of any other disease site. Attention should be
paid to similar cases in the future, to achieve a better un-
derstanding of the behavior of GCTs, especially teratomas.
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